AbstractMetastasis is characterized by the ability of cancer cells to invade into adjacent tissue, intravasate into blood or lymphatic vessels, and extravasate into a distant tissue. Metastatic disease is primarily responsible for the low 5-year survival rate of non-small cell lung cancer (NSCLC), and therefore, an understanding of the molecular mechanisms that regulate NSCLC metastasis is clearly warranted. The serine/threonine kinase and tumor suppressor LKB1 is mutated in 30% of NSCLC tumors, and recent evidence points to a prominent role in NSCLC metastasis. This review summarizes LKB1-dependent invasion pathways where compromised LKB1 function could promote NSCLC metastasis
In mice, Lkb1 deletion and activation of KrasG12D results in lung tumors with a high penetrance of l...
The kinase LKB1 is a tumor suppressor mutated in familial and sporadic human cancers, whose loss is ...
Globally, lung cancer is the most common cause of cancer-related deaths. After diagnosis at all stag...
AbstractMetastasis is characterized by the ability of cancer cells to invade into adjacent tissue, i...
In this issue of Cancer Cell, Carretero and colleagues report that Src and FAK signaling pathways ar...
Germline mutation in serine/threonine kinase 11 (STK11, also called LKB1) results in Peutz-Jeghers s...
Introduction:Inactivation of serine/threonine kinase 11 (STK11 or LKB1) is common in lung cancer, an...
Three phenotypically related genetic syndromes and their lesions (LKB1, PTEN, and TSC1/2) are identi...
SummaryIn mice, Lkb1 deletion and activation of KrasG12D results in lung tumors with a high penetran...
LKB1 is the second most commonly altered tumour suppressor gene in lung adenocarcinoma, the most pre...
Abstract LKB1/STK11 is a tumor suppressor gene that was originally identified in an a...
cancer genetic alterations, studies defining the pathways deregulated in tumor progression and metas...
SummaryIn mice, Lkb1 deletion and activation of KrasG12D results in lung tumors with a high penetran...
STK11/LKB1, a serine/threonine protein kinase and tumor suppressor, is a key upstream kinase of aden...
abstract: Non-small cell lung cancer (NSCLC) has become the leading cause of cancer-related deaths i...
In mice, Lkb1 deletion and activation of KrasG12D results in lung tumors with a high penetrance of l...
The kinase LKB1 is a tumor suppressor mutated in familial and sporadic human cancers, whose loss is ...
Globally, lung cancer is the most common cause of cancer-related deaths. After diagnosis at all stag...
AbstractMetastasis is characterized by the ability of cancer cells to invade into adjacent tissue, i...
In this issue of Cancer Cell, Carretero and colleagues report that Src and FAK signaling pathways ar...
Germline mutation in serine/threonine kinase 11 (STK11, also called LKB1) results in Peutz-Jeghers s...
Introduction:Inactivation of serine/threonine kinase 11 (STK11 or LKB1) is common in lung cancer, an...
Three phenotypically related genetic syndromes and their lesions (LKB1, PTEN, and TSC1/2) are identi...
SummaryIn mice, Lkb1 deletion and activation of KrasG12D results in lung tumors with a high penetran...
LKB1 is the second most commonly altered tumour suppressor gene in lung adenocarcinoma, the most pre...
Abstract LKB1/STK11 is a tumor suppressor gene that was originally identified in an a...
cancer genetic alterations, studies defining the pathways deregulated in tumor progression and metas...
SummaryIn mice, Lkb1 deletion and activation of KrasG12D results in lung tumors with a high penetran...
STK11/LKB1, a serine/threonine protein kinase and tumor suppressor, is a key upstream kinase of aden...
abstract: Non-small cell lung cancer (NSCLC) has become the leading cause of cancer-related deaths i...
In mice, Lkb1 deletion and activation of KrasG12D results in lung tumors with a high penetrance of l...
The kinase LKB1 is a tumor suppressor mutated in familial and sporadic human cancers, whose loss is ...
Globally, lung cancer is the most common cause of cancer-related deaths. After diagnosis at all stag...